Cargando…
A clinical metabolomics-based biomarker signature as an approach for early diagnosis of gastric cardia adenocarcinoma
Gastric cardia adenocarcinoma (GCA) has a high mortality rate worldwide; however, current early diagnostic methods lack efficacy. Therefore, the aim of the present study was to identify potential biomarkers for the early diagnosis of GCA. Global metabolic profiles were obtained from plasma samples c...
Autores principales: | Sun, Yuanfang, Li, Shasha, Li, Jin, Xiao, Xue, Hua, Zhaolai, Wang, Xi, Yan, Shikai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924188/ https://www.ncbi.nlm.nih.gov/pubmed/31897184 http://dx.doi.org/10.3892/ol.2019.11173 |
Ejemplares similares
-
Comparative analysis of gene expression profiles of gastric cardia adenocarcinoma and gastric non-cardia adenocarcinoma
por: Song, Bin, et al.
Publicado: (2016) -
Allelotype analysis of adenocarcinoma of the gastric cardia.
por: Gleeson, C. M., et al.
Publicado: (1997) -
Gastric cardia adenocarcinoma pathway analysis
por: Zali, Hakimeh, et al.
Publicado: (2013) -
Survival influence of gender on 42,345 patients with gastric cardia adenocarcinoma
por: Xu, Rui Hua, et al.
Publicado: (2022) -
CYR61 (CCN1) is a metastatic biomarker of gastric cardia adenocarcinoma
por: Wei, Jing, et al.
Publicado: (2016)